Your Partner in Novel Drug Development

Teva Pharmaceutical Industries Ltd. is a top 20 global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals. Teva operates in more than 50 countries and employs approximately 28,000 people. We offer the widest range of cost-effective pharmaceuticals, both generic and branded, to patients and healthcare providers. Known as the leading generic company worldwide, Teva also is committed to developing proprietary (innovative) pharmaceutical products through in-licensing pre-clinical and clinicals stage compounds.

Teva Partners is a program that seeks partnerships with companies and academic institutions.

Flexible. Innovative. Committed.

Every aspect of our business is geared toward building mutually beneficial partnerships in order to develop new specialty medicines.

What do we offer smaller companies and academic institutions that want to partner with a well-established leader in the global pharmaceuticals market?

Reasons to Partner with Teva
Proven Success
Genuine Commitment
Unmatched Flexibility
Specialized Development

Please select one of the options to the left.

Proven Success

We're building on the successes of Teva Pharmaceutical Industries Ltd. by developing proprietary therapies such as the blockbuster COPAXONE® and AZILECT® – the rights to both of which were acquired from renowned institutes.

Genuine Commitment

We are highly selective about the projects that pass our approval process. Projects that are selected for partnering receive our concentrated efforts.

Unmatched Deal Flexibility

The structure and terms for each deal are negotiated to create a win-win situation for both Teva and our partners.

Reliance on External Research & Partnering

We strive to become a partner of choice as Teva's Innovative business depends primarily on in-licensing and partnering to obtain products for development.

Join us in our commitment to innovation

If you seek a development and commercialization partner with the global resources and expertise to streamline the development, regulatory, manufacturing, sales and marketing and reimbursement processes, we invite you to review our areas of interest. We look forward to a mutually beneficial partnership.

Legal Note